Physician profile
Summit Pandat
NPI 1922454099
$46,432.21
in general payments reported to CMS, 2019-2025
25 companies · $5,778 in 2025
The $5,778 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $226 · 2021: $1,505 · 2022: $8,109 · 2023: $15K · 2024: $15K · 2025: $5,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $14K · Grant: $6,310 · Education: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,892.85 |
| Food and Beverage | $14,353.56 |
| Grant | $6,309.98 |
| Education | $1,036.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,473.44 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $11,788.52 | 2021-2025 | Ensite Precision, Amplatzer Amulet, Ensite |
| Boston Scientific Corporation | $11,476.03 | 2022-2025 | Versacross Access Solution, S-Icd System Magnet, Farapulse |
| Biosense Webster, INC. | $1,786.50 | 2024-2025 | Carto 3, Qdot Micro, Soundstar |
| Biotronik INC. | $1,304.90 | 2022-2025 | Pamira, Acticor 7 Vr-T Dx |
| Amgen INC. | $591.60 | 2021-2023 | Repatha |
| Abiomed | $359.30 | 2022-2024 | Impella |
| Actelion Pharmaceuticals US, INC. | $214.53 | 2022-2023 | Opsumit, Uptravi |
| Impulse Dynamics (USA) INC. | $197.24 | 2022 | |
| Pfizer INC. | $145.91 | 2020-2023 | |
| Cook Incorporated | $140.85 | 2020 | |
| Ethicon US, LLC | $139.26 | 2025 | Vistaseal, Ethicon, Dermabond Prineo |
| Cardiva Medical, INC. | $134.24 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.38 | 2022-2023 | Jardiance |
| Heartflow, INC. | $113.08 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $110.80 | 2024 | Alphavac, Angiovac |
| Sanofi-Aventis U.S. LLC | $92.37 | 2022 | |
| Getinge USA Sales, LLC | $65.59 | 2020 | |
| W. L. Gore & Associates, INC. | $53.38 | 2022-2023 | Gore Cardioform Septal Occluder |
| Alnylam Pharmaceuticals INC. | $29.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.37 | 2023 | |
| Teleflex LLC | $20.28 | 2023 | Vascband |
| Kiniksa Pharmaceuticals, LTD. | $16.79 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $14.46 | 2022 | |
| Tactile Systems Technology INC | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summit Pandat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.